

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | low-density lipoprotein particle remodeling (GO:0034374) | 9.75221606 |
| 2 | intestinal epithelial cell development (GO:0060576) | 9.21266665 |
| 3 | lung secretory cell differentiation (GO:0061140) | 8.12015839 |
| 4 | bile acid and bile salt transport (GO:0015721) | 7.99463182 |
| 5 | axonemal dynein complex assembly (GO:0070286) | 7.82814268 |
| 6 | intestinal absorption (GO:0050892) | 6.87239456 |
| 7 | hepatocyte apoptotic process (GO:0097284) | 6.60229953 |
| 8 | positive regulation of macrophage derived foam cell differentiation (GO:0010744) | 6.58679180 |
| 9 | maintenance of gastrointestinal epithelium (GO:0030277) | 6.34047340 |
| 10 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 6.09178276 |
| 11 | sulfation (GO:0051923) | 6.08895327 |
| 12 | regulation of guanylate cyclase activity (GO:0031282) | 5.89731978 |
| 13 | glandular epithelial cell differentiation (GO:0002067) | 5.83943176 |
| 14 | vitamin transmembrane transport (GO:0035461) | 5.81887283 |
| 15 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 5.73234379 |
| 16 | positive regulation of respiratory burst (GO:0060267) | 5.71006550 |
| 17 | cilium or flagellum-dependent cell motility (GO:0001539) | 5.66812356 |
| 18 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 5.62237351 |
| 19 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 5.47569562 |
| 20 | plasma lipoprotein particle remodeling (GO:0034369) | 5.47223899 |
| 21 | protein-lipid complex remodeling (GO:0034368) | 5.47223899 |
| 22 | macromolecular complex remodeling (GO:0034367) | 5.47223899 |
| 23 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 5.32383195 |
| 24 | primary alcohol catabolic process (GO:0034310) | 5.28257549 |
| 25 | ethanol oxidation (GO:0006069) | 5.27467990 |
| 26 | antibacterial humoral response (GO:0019731) | 5.15709103 |
| 27 | ethanol metabolic process (GO:0006067) | 5.05595510 |
| 28 | cilium movement (GO:0003341) | 5.04269527 |
| 29 | motile cilium assembly (GO:0044458) | 5.02670468 |
| 30 | antimicrobial humoral response (GO:0019730) | 4.98488661 |
| 31 | digestive system process (GO:0022600) | 4.90599757 |
| 32 | intestinal cholesterol absorption (GO:0030299) | 4.84764854 |
| 33 | phosphatidylglycerol acyl-chain remodeling (GO:0036148) | 4.79729289 |
| 34 | positive regulation of cellular response to insulin stimulus (GO:1900078) | 4.73667819 |
| 35 | regulation of norepinephrine secretion (GO:0014061) | 4.64383107 |
| 36 | epoxygenase P450 pathway (GO:0019373) | 4.63788882 |
| 37 | epithelial structure maintenance (GO:0010669) | 4.62814425 |
| 38 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 4.55357423 |
| 39 | positive regulation of pseudopodium assembly (GO:0031274) | 4.55357045 |
| 40 | galactose catabolic process (GO:0019388) | 4.52890319 |
| 41 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 4.46534069 |
| 42 | positive regulation of guanylate cyclase activity (GO:0031284) | 4.42886988 |
| 43 | plasma lipoprotein particle organization (GO:0071827) | 4.42497782 |
| 44 | oligosaccharide biosynthetic process (GO:0009312) | 4.41160293 |
| 45 | phosphatidylserine metabolic process (GO:0006658) | 4.38680470 |
| 46 | galactose metabolic process (GO:0006012) | 4.37497414 |
| 47 | protein-lipid complex subunit organization (GO:0071825) | 4.34635697 |
| 48 | proline biosynthetic process (GO:0006561) | 4.34549233 |
| 49 | bile acid metabolic process (GO:0008206) | 4.33183294 |
| 50 | epithelial cilium movement (GO:0003351) | 4.32475946 |
| 51 | glomerular filtration (GO:0003094) | 4.30777887 |
| 52 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 4.28507921 |
| 53 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 4.20152910 |
| 54 | O-glycan processing (GO:0016266) | 4.10182867 |
| 55 | phosphatidylethanolamine acyl-chain remodeling (GO:0036152) | 4.10098968 |
| 56 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.09061813 |
| 57 | regulation of pseudopodium assembly (GO:0031272) | 4.07204726 |
| 58 | regulation of respiratory burst (GO:0060263) | 4.05100477 |
| 59 | negative regulation of keratinocyte proliferation (GO:0010839) | 4.02163165 |
| 60 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.97819999 |
| 61 | renal filtration (GO:0097205) | 3.90411734 |
| 62 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 3.85126541 |
| 63 | regulation of bile acid biosynthetic process (GO:0070857) | 3.84559019 |
| 64 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 3.83932013 |
| 65 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 3.83932013 |
| 66 | endocrine process (GO:0050886) | 3.83932013 |
| 67 | fructose metabolic process (GO:0006000) | 3.81968346 |
| 68 | tumor necrosis factor-mediated signaling pathway (GO:0033209) | 3.78701232 |
| 69 | regulation of hydrogen peroxide metabolic process (GO:0010310) | 3.75337640 |
| 70 | lipoprotein transport (GO:0042953) | 3.72021091 |
| 71 | negative regulation of cell fate commitment (GO:0010454) | 3.65832744 |
| 72 | alditol phosphate metabolic process (GO:0052646) | 3.63040918 |
| 73 | regulation of cellular extravasation (GO:0002691) | 3.61209858 |
| 74 | ATP synthesis coupled proton transport (GO:0015986) | 3.58720668 |
| 75 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.58720668 |
| 76 | lung epithelial cell differentiation (GO:0060487) | 3.58699278 |
| 77 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.57359275 |
| 78 | lung cell differentiation (GO:0060479) | 3.57196817 |
| 79 | regulation of cGMP biosynthetic process (GO:0030826) | 3.57121483 |
| 80 | regulation of viral entry into host cell (GO:0046596) | 3.56571769 |
| 81 | eosinophil chemotaxis (GO:0048245) | 3.54684668 |
| 82 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 3.52433614 |
| 83 | drug metabolic process (GO:0017144) | 3.52285758 |
| 84 | exogenous drug catabolic process (GO:0042738) | 3.52011557 |
| 85 | mucosal immune response (GO:0002385) | 3.51091245 |
| 86 | sulfur amino acid catabolic process (GO:0000098) | 3.46471152 |
| 87 | regulation of systemic arterial blood pressure (GO:0003073) | 3.45032901 |
| 88 | renal system process involved in regulation of blood volume (GO:0001977) | 3.44772288 |
| 89 | diterpenoid biosynthetic process (GO:0016102) | 3.44681268 |
| 90 | complement activation, classical pathway (GO:0006958) | 3.42855642 |
| 91 | glutathione biosynthetic process (GO:0006750) | 3.35826998 |
| 92 | phosphatidylcholine acyl-chain remodeling (GO:0036151) | 3.33144591 |
| 93 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.32670419 |
| 94 | transcytosis (GO:0045056) | 3.32425005 |
| 95 | organ or tissue specific immune response (GO:0002251) | 3.31077580 |
| 96 | positive regulation of glycoprotein metabolic process (GO:1903020) | 3.29551348 |
| 97 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 3.28765391 |
| 98 | flavonoid metabolic process (GO:0009812) | 3.28198323 |
| 99 | nonribosomal peptide biosynthetic process (GO:0019184) | 3.28189063 |
| 100 | drug catabolic process (GO:0042737) | 3.27953065 |
| 101 | primary alcohol metabolic process (GO:0034308) | 3.26699313 |
| 102 | N-acetylglucosamine metabolic process (GO:0006044) | 3.26391238 |
| 103 | positive regulation of epidermal cell differentiation (GO:0045606) | 3.24591363 |
| 104 | GDP-mannose metabolic process (GO:0019673) | 3.24096441 |
| 105 | diacylglycerol metabolic process (GO:0046339) | 3.22095449 |
| 106 | hormone catabolic process (GO:0042447) | 3.21808957 |
| 107 | glucuronate metabolic process (GO:0019585) | 3.21446817 |
| 108 | uronic acid metabolic process (GO:0006063) | 3.21446817 |
| 109 | multicellular organismal water homeostasis (GO:0050891) | 3.18553662 |
| 110 | axoneme assembly (GO:0035082) | 3.18382128 |
| 111 | actin filament depolymerization (GO:0030042) | 3.17601504 |
| 112 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.16976141 |
| 113 | peptide catabolic process (GO:0043171) | 3.16642109 |
| 114 | regulation of vitamin metabolic process (GO:0030656) | 3.16514165 |
| 115 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.15803148 |
| 116 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 3.15673800 |
| 117 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 3.15673800 |
| 118 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.15406319 |
| 119 | eosinophil migration (GO:0072677) | 3.15295731 |
| 120 | cellular glucuronidation (GO:0052695) | 3.15254961 |
| 121 | regulation of cytokine secretion involved in immune response (GO:0002739) | 3.15114261 |
| 122 | proline metabolic process (GO:0006560) | 3.13493663 |
| 123 | angiotensin maturation (GO:0002003) | 3.12618896 |
| 124 | vitamin transport (GO:0051180) | 3.11923843 |
| 125 | sphingomyelin metabolic process (GO:0006684) | 3.11327847 |
| 126 | regulation of keratinocyte proliferation (GO:0010837) | 3.10734497 |
| 127 | regulation of actin nucleation (GO:0051125) | 3.10517681 |
| 128 | negative regulation of epidermal cell differentiation (GO:0045605) | 3.10470287 |
| 129 | cell differentiation involved in embryonic placenta development (GO:0060706) | 3.06603434 |
| 130 | sodium ion homeostasis (GO:0055078) | 3.06601559 |
| 131 | urea metabolic process (GO:0019627) | 3.06445054 |
| 132 | urea cycle (GO:0000050) | 3.06445054 |
| 133 | negative regulation of protein tyrosine kinase activity (GO:0061099) | 3.05244327 |
| 134 | leukocyte tethering or rolling (GO:0050901) | 3.04811365 |
| 135 | phosphatidic acid metabolic process (GO:0046473) | 3.04773777 |
| 136 | phosphatidic acid biosynthetic process (GO:0006654) | 3.04773777 |
| 137 | sperm capacitation (GO:0048240) | 3.03172216 |
| 138 | * digestion (GO:0007586) | 3.02872436 |
| 139 | excretion (GO:0007588) | 3.02202296 |
| 140 | nucleoside diphosphate biosynthetic process (GO:0009133) | 3.01744136 |
| 141 | glucose 6-phosphate metabolic process (GO:0051156) | 3.00557079 |
| 142 | positive regulation of chemokine secretion (GO:0090197) | 2.98888982 |
| 143 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.98374214 |
| 144 | adhesion of symbiont to host cell (GO:0044650) | 2.97073465 |
| 145 | virion attachment to host cell (GO:0019062) | 2.97073465 |
| 146 | regulation of cGMP metabolic process (GO:0030823) | 2.95778559 |
| 147 | retinol metabolic process (GO:0042572) | 2.95675366 |
| 148 | glycolipid catabolic process (GO:0019377) | 2.94893012 |
| 149 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.94451389 |
| 150 | glutathione metabolic process (GO:0006749) | 2.94401578 |
| 151 | glycosphingolipid catabolic process (GO:0046479) | 2.93952895 |
| 152 | vitamin A metabolic process (GO:0006776) | 2.90531288 |
| 153 | positive regulation of glucose import (GO:0046326) | 2.89846705 |
| 154 | regulation of hormone biosynthetic process (GO:0046885) | 2.89564992 |
| 155 | desmosome organization (GO:0002934) | 2.86575036 |
| 156 | positive regulation of cytokine production involved in immune response (GO:0002720) | 2.85922878 |
| 157 | columnar/cuboidal epithelial cell development (GO:0002066) | 2.85606894 |
| 158 | glutathione derivative biosynthetic process (GO:1901687) | 2.85521334 |
| 159 | glutathione derivative metabolic process (GO:1901685) | 2.85521334 |
| 160 | cysteine metabolic process (GO:0006534) | 2.85476105 |
| 161 | protein O-linked glycosylation (GO:0006493) | 2.85185762 |
| 162 | defense response to Gram-positive bacterium (GO:0050830) | 2.84088020 |
| 163 | cellular response to fatty acid (GO:0071398) | 2.83656683 |
| 164 | nucleotide transmembrane transport (GO:1901679) | 2.83339544 |
| 165 | arginine metabolic process (GO:0006525) | 2.82929191 |
| 166 | negative regulation of T cell differentiation in thymus (GO:0033085) | 2.82704121 |
| 167 | ventricular cardiac muscle cell action potential (GO:0086005) | 2.82409527 |
| 168 | regulation of cell-cell adhesion mediated by cadherin (GO:2000047) | 2.81480141 |
| 169 | regulation of chemokine secretion (GO:0090196) | 2.81358284 |
| 170 | positive regulation of glucose transport (GO:0010828) | 2.80218999 |
| 171 | glycosylceramide metabolic process (GO:0006677) | 2.78989100 |
| 172 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.76981753 |
| 173 | nitrogen cycle metabolic process (GO:0071941) | 2.76658177 |
| 174 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.74978902 |
| 175 | cardiac conduction (GO:0061337) | 2.72601908 |
| 176 | NADH metabolic process (GO:0006734) | 2.64364640 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 6.09336760 |
| 2 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 4.73204435 |
| 3 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 4.31641865 |
| 4 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.25388830 |
| 5 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 3.62077857 |
| 6 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.60569374 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.60055172 |
| 8 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 3.18353565 |
| 9 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 3.06540401 |
| 10 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 3.02975989 |
| 11 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.99998820 |
| 12 | GATA4_25053715_ChIP-Seq_YYC3_Human | 2.87622056 |
| 13 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.84300911 |
| 14 | GATA6_25053715_ChIP-Seq_YYC3_Human | 2.71584458 |
| 15 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.66897293 |
| 16 | * SOX2_20726797_ChIP-Seq_SW620_Human | 2.64598853 |
| 17 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.50894853 |
| 18 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.39693585 |
| 19 | * THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.28660496 |
| 20 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 2.20978844 |
| 21 | * STAT1_20625510_ChIP-Seq_HELA_Human | 2.06559755 |
| 22 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.06469419 |
| 23 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.97733603 |
| 24 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.92835883 |
| 25 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.80306601 |
| 26 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.71381821 |
| 27 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.64962256 |
| 28 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.64177028 |
| 29 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.63880387 |
| 30 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.62667199 |
| 31 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.61193816 |
| 32 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.60171337 |
| 33 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.57595903 |
| 34 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.56522956 |
| 35 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.54623124 |
| 36 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.47206517 |
| 37 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.46290748 |
| 38 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.44937387 |
| 39 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.44032547 |
| 40 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.42506777 |
| 41 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.40025047 |
| 42 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.39158771 |
| 43 | * FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.38639734 |
| 44 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.37373678 |
| 45 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.37357296 |
| 46 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.35980210 |
| 47 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.33312751 |
| 48 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.33023773 |
| 49 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.30944479 |
| 50 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.30889779 |
| 51 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.29829386 |
| 52 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.29561662 |
| 53 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.29337938 |
| 54 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.28195850 |
| 55 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.28060451 |
| 56 | GATA2_19941826_ChIP-Seq_K562_Human | 1.27504990 |
| 57 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.25819937 |
| 58 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.24551558 |
| 59 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.22894922 |
| 60 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.21680244 |
| 61 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.16895525 |
| 62 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.15794724 |
| 63 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.15432438 |
| 64 | ATF3_27146783_Chip-Seq_COLON_Human | 1.14709495 |
| 65 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.13227433 |
| 66 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.13069816 |
| 67 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.12981454 |
| 68 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.12595104 |
| 69 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.12230342 |
| 70 | GATA1_19941826_ChIP-Seq_K562_Human | 1.11918755 |
| 71 | * SA1_27219007_Chip-Seq_Bcells_Human | 1.10694198 |
| 72 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.09849058 |
| 73 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.09380425 |
| 74 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.08750550 |
| 75 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.08441598 |
| 76 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.08284685 |
| 77 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.07466091 |
| 78 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.06904240 |
| 79 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.05826289 |
| 80 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.05682667 |
| 81 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.05168455 |
| 82 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.04868225 |
| 83 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.04069171 |
| 84 | * FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.03725086 |
| 85 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.03481674 |
| 86 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.03235710 |
| 87 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.03155498 |
| 88 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.02585931 |
| 89 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.02217974 |
| 90 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.00779773 |
| 91 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.00558549 |
| 92 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 1.00281496 |
| 93 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.99375478 |
| 94 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.97131498 |
| 95 | * PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.96895850 |
| 96 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.96769630 |
| 97 | * RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.96508425 |
| 98 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.95505935 |
| 99 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.94632079 |
| 100 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.94081871 |
| 101 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.93581142 |
| 102 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.92027319 |
| 103 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.91896765 |
| 104 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.91392340 |
| 105 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.90884637 |
| 106 | P68_20966046_ChIP-Seq_HELA_Human | 0.90769353 |
| 107 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.90690883 |
| 108 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.89352789 |
| 109 | * CEBPB_22108803_ChIP-Seq_LS180_Human | 0.89351469 |
| 110 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.89044485 |
| 111 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.88655180 |
| 112 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.88445179 |
| 113 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.88106279 |
| 114 | * GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.87660018 |
| 115 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.87475413 |
| 116 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.86653952 |
| 117 | P300_27268052_Chip-Seq_Bcells_Human | 0.86159100 |
| 118 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.85780814 |
| 119 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.85532845 |
| 120 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.85469578 |
| 121 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.85264705 |
| 122 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 0.83799013 |
| 123 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.82820467 |
| 124 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.82762398 |
| 125 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.82482438 |
| 126 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.82419700 |
| 127 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.82383533 |
| 128 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.81434951 |
| 129 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.81320317 |
| 130 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.81008838 |
| 131 | * MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.79902395 |
| 132 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.79007942 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 6.81384910 |
| 2 | MP0001666_abnormal_nutrient_absorption | 4.78945210 |
| 3 | MP0004264_abnormal_extraembryonic_tissu | 4.51668544 |
| 4 | MP0003868_abnormal_feces_composition | 4.36965655 |
| 5 | MP0001873_stomach_inflammation | 3.90676102 |
| 6 | MP0002139_abnormal_hepatobiliary_system | 3.81752168 |
| 7 | MP0003866_abnormal_defecation | 3.72131237 |
| 8 | MP0000490_abnormal_crypts_of | 3.71931779 |
| 9 | MP0005085_abnormal_gallbladder_physiolo | 3.39847647 |
| 10 | MP0010234_abnormal_vibrissa_follicle | 3.36891801 |
| 11 | * MP0010155_abnormal_intestine_physiology | 3.14881886 |
| 12 | MP0001663_abnormal_digestive_system | 3.05676250 |
| 13 | MP0000462_abnormal_digestive_system | 3.04079197 |
| 14 | MP0004043_abnormal_pH_regulation | 2.96413498 |
| 15 | MP0008875_abnormal_xenobiotic_pharmacok | 2.77571653 |
| 16 | MP0003252_abnormal_bile_duct | 2.61189861 |
| 17 | MP0005365_abnormal_bile_salt | 2.56692940 |
| 18 | MP0005381_digestive/alimentary_phenotyp | 2.55316535 |
| 19 | MP0005666_abnormal_adipose_tissue | 2.30674934 |
| 20 | MP0001664_abnormal_digestion | 2.27034734 |
| 21 | * MP0000477_abnormal_intestine_morphology | 2.25971822 |
| 22 | MP0002277_abnormal_respiratory_mucosa | 2.09542031 |
| 23 | MP0000537_abnormal_urethra_morphology | 2.07855124 |
| 24 | MP0003806_abnormal_nucleotide_metabolis | 2.07764373 |
| 25 | MP0002876_abnormal_thyroid_physiology | 2.02904649 |
| 26 | MP0005409_darkened_coat_color | 2.02741438 |
| 27 | MP0004147_increased_porphyrin_level | 2.00798184 |
| 28 | MP0004019_abnormal_vitamin_homeostasis | 1.98139797 |
| 29 | MP0003705_abnormal_hypodermis_morpholog | 1.91921593 |
| 30 | MP0000465_gastrointestinal_hemorrhage | 1.83775751 |
| 31 | MP0003183_abnormal_peptide_metabolism | 1.83628382 |
| 32 | MP0003191_abnormal_cellular_cholesterol | 1.79682533 |
| 33 | MP0008004_abnormal_stomach_pH | 1.72519968 |
| 34 | MP0010352_gastrointestinal_tract_polyps | 1.68364274 |
| 35 | MP0009840_abnormal_foam_cell | 1.66080360 |
| 36 | MP0010329_abnormal_lipoprotein_level | 1.65959895 |
| 37 | MP0003300_gastrointestinal_ulcer | 1.64542609 |
| 38 | MP0000566_synostosis | 1.59777456 |
| 39 | MP0002132_abnormal_respiratory_system | 1.57446975 |
| 40 | MP0009780_abnormal_chondrocyte_physiolo | 1.52706850 |
| 41 | MP0004858_abnormal_nervous_system | 1.45004229 |
| 42 | MP0005451_abnormal_body_composition | 1.43468977 |
| 43 | MP0002822_catalepsy | 1.40101879 |
| 44 | MP0002653_abnormal_ependyma_morphology | 1.31989915 |
| 45 | MP0005448_abnormal_energy_balance | 1.28792676 |
| 46 | MP0005375_adipose_tissue_phenotype | 1.27483023 |
| 47 | MP0003879_abnormal_hair_cell | 1.19880600 |
| 48 | MP0000681_abnormal_thyroid_gland | 1.18472126 |
| 49 | MP0003724_increased_susceptibility_to | 1.16014961 |
| 50 | MP0003878_abnormal_ear_physiology | 1.13041338 |
| 51 | MP0005377_hearing/vestibular/ear_phenot | 1.13041338 |
| 52 | MP0009643_abnormal_urine_homeostasis | 1.11195309 |
| 53 | MP0003303_peritoneal_inflammation | 1.10624496 |
| 54 | MP0005332_abnormal_amino_acid | 1.10133607 |
| 55 | MP0002118_abnormal_lipid_homeostasis | 1.09770403 |
| 56 | MP0001849_ear_inflammation | 1.08482277 |
| 57 | MP0001756_abnormal_urination | 1.07181478 |
| 58 | MP0001188_hyperpigmentation | 1.04419552 |
| 59 | MP0003123_paternal_imprinting | 1.02584927 |
| 60 | MP0002909_abnormal_adrenal_gland | 1.01598072 |
| 61 | MP0002796_impaired_skin_barrier | 0.96903135 |
| 62 | MP0005166_decreased_susceptibility_to | 0.96664461 |
| 63 | MP0002896_abnormal_bone_mineralization | 0.96096375 |
| 64 | MP0000470_abnormal_stomach_morphology | 0.95795642 |
| 65 | MP0001764_abnormal_homeostasis | 0.95591788 |
| 66 | MP0004185_abnormal_adipocyte_glucose | 0.93877848 |
| 67 | MP0002166_altered_tumor_susceptibility | 0.92663621 |
| 68 | MP0001790_abnormal_immune_system | 0.90809143 |
| 69 | MP0005387_immune_system_phenotype | 0.90809143 |
| 70 | MP0006054_spinal_hemorrhage | 0.89928804 |
| 71 | MP0008872_abnormal_physiological_respon | 0.88328766 |
| 72 | MP0002138_abnormal_hepatobiliary_system | 0.86109752 |
| 73 | MP0000538_abnormal_urinary_bladder | 0.85468127 |
| 74 | MP0005310_abnormal_salivary_gland | 0.84577159 |
| 75 | MP0005083_abnormal_biliary_tract | 0.83604055 |
| 76 | MP0000609_abnormal_liver_physiology | 0.83465026 |
| 77 | MP0005025_abnormal_response_to | 0.81488738 |
| 78 | MP0005334_abnormal_fat_pad | 0.77677364 |
| 79 | MP0000383_abnormal_hair_follicle | 0.77220056 |
| 80 | MP0006082_CNS_inflammation | 0.75084179 |
| 81 | MP0010030_abnormal_orbit_morphology | 0.74755727 |
| 82 | MP0001485_abnormal_pinna_reflex | 0.72974031 |
| 83 | MP0001881_abnormal_mammary_gland | 0.72910618 |
| 84 | MP0002249_abnormal_larynx_morphology | 0.72720346 |
| 85 | MP0003329_amyloid_beta_deposits | 0.72596061 |
| 86 | * MP0001845_abnormal_inflammatory_respons | 0.71080016 |
| 87 | MP0001765_abnormal_ion_homeostasis | 0.68259333 |
| 88 | MP0005058_abnormal_lysosome_morphology | 0.67207303 |
| 89 | MP0001835_abnormal_antigen_presentation | 0.66726150 |
| 90 | MP0005319_abnormal_enzyme/_coenzyme | 0.66570471 |
| 91 | MP0005408_hypopigmentation | 0.63606735 |
| 92 | MP0003718_maternal_effect | 0.63444671 |
| 93 | MP0005076_abnormal_cell_differentiation | 0.62566181 |
| 94 | MP0004947_skin_inflammation | 0.61210330 |
| 95 | MP0002148_abnormal_hypersensitivity_rea | 0.61148741 |
| 96 | MP0010678_abnormal_skin_adnexa | 0.60964801 |
| 97 | MP0000013_abnormal_adipose_tissue | 0.60491536 |
| 98 | MP0003828_pulmonary_edema | 0.60130374 |
| 99 | MP0009379_abnormal_foot_pigmentation | 0.59827232 |
| 100 | MP0000858_altered_metastatic_potential | 0.59824127 |
| 101 | MP0005084_abnormal_gallbladder_morpholo | 0.58849174 |
| 102 | MP0000249_abnormal_blood_vessel | 0.57820925 |
| 103 | MP0003638_abnormal_response/metabolism_ | 0.57603661 |
| 104 | MP0001501_abnormal_sleep_pattern | 0.57334134 |
| 105 | MP0001533_abnormal_skeleton_physiology | 0.57207702 |
| 106 | MP0004484_altered_response_of | 0.56490171 |
| 107 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.55763938 |
| 108 | MP0004270_analgesia | 0.54324526 |
| 109 | MP0003075_altered_response_to | 0.53147566 |
| 110 | MP0002089_abnormal_postnatal_growth/wei | 0.52865563 |
| 111 | MP0009053_abnormal_anal_canal | 0.51408909 |
| 112 | MP0009642_abnormal_blood_homeostasis | 0.50229792 |
| 113 | MP0010386_abnormal_urinary_bladder | 0.50125278 |
| 114 | MP0003453_abnormal_keratinocyte_physiol | 0.50001576 |
| 115 | MP0000467_abnormal_esophagus_morphology | 0.49185145 |
| 116 | MP0001440_abnormal_grooming_behavior | 0.49009255 |
| 117 | MP0005636_abnormal_mineral_homeostasis | 0.47597489 |
| 118 | MP0002136_abnormal_kidney_physiology | 0.47565294 |
| 119 | MP0004782_abnormal_surfactant_physiolog | 0.47329742 |
| 120 | MP0005501_abnormal_skin_physiology | 0.47224316 |
| 121 | MP0005167_abnormal_blood-brain_barrier | 0.46235168 |
| 122 | MP0002254_reproductive_system_inflammat | 0.46015428 |
| 123 | MP0002098_abnormal_vibrissa_morphology | 0.43847586 |
| 124 | MP0001958_emphysema | 0.42808434 |
| 125 | MP0001216_abnormal_epidermal_layer | 0.41398890 |
| 126 | MP0003656_abnormal_erythrocyte_physiolo | 0.41261463 |
| 127 | MP0003315_abnormal_perineum_morphology | 0.40350975 |
| 128 | MP0000678_abnormal_parathyroid_gland | 0.40309149 |
| 129 | MP0009785_altered_susceptibility_to | 0.40104834 |
| 130 | MP0003283_abnormal_digestive_organ | 0.39951766 |
| 131 | MP0005023_abnormal_wound_healing | 0.38765686 |
| 132 | MP0008873_increased_physiological_sensi | 0.38425930 |
| 133 | MP0000598_abnormal_liver_morphology | 0.37067889 |
| 134 | MP0008469_abnormal_protein_level | 0.36115347 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 7.98165439 |
| 2 | Abnormal respiratory motile cilium morphology (HP:0005938) | 6.90993982 |
| 3 | Abnormal respiratory epithelium morphology (HP:0012253) | 6.90993982 |
| 4 | Abnormal respiratory motile cilium physiology (HP:0012261) | 6.89762106 |
| 5 | Rhinitis (HP:0012384) | 6.71688866 |
| 6 | Abnormal ciliary motility (HP:0012262) | 6.56691806 |
| 7 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 6.42314193 |
| 8 | Absent/shortened dynein arms (HP:0200106) | 6.42314193 |
| 9 | Chronic bronchitis (HP:0004469) | 6.10767144 |
| 10 | Hyperactive renin-angiotensin system (HP:0000841) | 5.97258667 |
| 11 | Micronodular cirrhosis (HP:0001413) | 5.74712082 |
| 12 | Nasal polyposis (HP:0100582) | 5.55630647 |
| 13 | Bronchiectasis (HP:0002110) | 5.37090469 |
| 14 | Ileus (HP:0002595) | 5.31330668 |
| 15 | Abnormality of the nasal mucosa (HP:0000433) | 5.18888638 |
| 16 | Abdominal distention (HP:0003270) | 4.99558689 |
| 17 | Decreased circulating renin level (HP:0003351) | 4.84410918 |
| 18 | Right ventricular cardiomyopathy (HP:0011663) | 4.63545821 |
| 19 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.58182629 |
| 20 | Late onset (HP:0003584) | 4.41342044 |
| 21 | Esophageal varix (HP:0002040) | 4.07466884 |
| 22 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 3.99705498 |
| 23 | Abnormality of renin-angiotensin system (HP:0000847) | 3.95416600 |
| 24 | Ventricular fibrillation (HP:0001663) | 3.93473822 |
| 25 | Congenital sensorineural hearing impairment (HP:0008527) | 3.89375357 |
| 26 | Syncope (HP:0001279) | 3.81170893 |
| 27 | Ketoacidosis (HP:0001993) | 3.81153501 |
| 28 | Abnormality of vitamin B metabolism (HP:0004340) | 3.78623723 |
| 29 | Bronchitis (HP:0012387) | 3.69777587 |
| 30 | Systemic lupus erythematosus (HP:0002725) | 3.68343231 |
| 31 | Chronic sinusitis (HP:0011109) | 3.47396131 |
| 32 | Recurrent sinusitis (HP:0011108) | 3.41845649 |
| 33 | Abnormality of vitamin metabolism (HP:0100508) | 3.37958304 |
| 34 | Bundle branch block (HP:0011710) | 3.26458704 |
| 35 | Malnutrition (HP:0004395) | 3.26404590 |
| 36 | Hyperparathyroidism (HP:0000843) | 3.25349547 |
| 37 | Alkalosis (HP:0001948) | 3.21994978 |
| 38 | Prolonged QT interval (HP:0001657) | 3.19203246 |
| 39 | Intrahepatic cholestasis (HP:0001406) | 3.15112146 |
| 40 | Posterior subcapsular cataract (HP:0007787) | 3.14506630 |
| 41 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.13804225 |
| 42 | Glycosuria (HP:0003076) | 3.02967033 |
| 43 | Abnormality of urine glucose concentration (HP:0011016) | 3.02967033 |
| 44 | Hypobetalipoproteinemia (HP:0003563) | 2.99471102 |
| 45 | Flat acetabular roof (HP:0003180) | 2.99146609 |
| 46 | Chronic otitis media (HP:0000389) | 2.98837498 |
| 47 | Hypercortisolism (HP:0001578) | 2.98790453 |
| 48 | Xanthomatosis (HP:0000991) | 2.95988892 |
| 49 | Metabolic alkalosis (HP:0200114) | 2.92648265 |
| 50 | Hyperaldosteronism (HP:0000859) | 2.91396388 |
| 51 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.87759026 |
| 52 | Abnormality of chloride homeostasis (HP:0011422) | 2.87298046 |
| 53 | Fat malabsorption (HP:0002630) | 2.84961811 |
| 54 | Palpitations (HP:0001962) | 2.82310492 |
| 55 | Woolly hair (HP:0002224) | 2.81328059 |
| 56 | Conjunctival hamartoma (HP:0100780) | 2.80954716 |
| 57 | Recurrent otitis media (HP:0000403) | 2.75753550 |
| 58 | Confusion (HP:0001289) | 2.72946046 |
| 59 | Increased muscle lipid content (HP:0009058) | 2.72894733 |
| 60 | Infertility (HP:0000789) | 2.71907008 |
| 61 | Hyperammonemia (HP:0001987) | 2.66437369 |
| 62 | Hypoglycemic coma (HP:0001325) | 2.63505358 |
| 63 | Ketosis (HP:0001946) | 2.62742332 |
| 64 | Generalized aminoaciduria (HP:0002909) | 2.62046878 |
| 65 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.60380232 |
| 66 | Insulin resistance (HP:0000855) | 2.57359304 |
| 67 | Glomerulonephritis (HP:0000099) | 2.50446661 |
| 68 | Chronic diarrhea (HP:0002028) | 2.50123651 |
| 69 | Bone cyst (HP:0012062) | 2.49436944 |
| 70 | Increased intramyocellular lipid droplets (HP:0012240) | 2.48727259 |
| 71 | Hydroxyprolinuria (HP:0003080) | 2.46788925 |
| 72 | Abnormality of proline metabolism (HP:0010907) | 2.46788925 |
| 73 | Conjugated hyperbilirubinemia (HP:0002908) | 2.45960083 |
| 74 | Male infertility (HP:0003251) | 2.45691338 |
| 75 | Chorioretinal atrophy (HP:0000533) | 2.43144855 |
| 76 | Abnormality of glycolysis (HP:0004366) | 2.42751437 |
| 77 | Increased serum pyruvate (HP:0003542) | 2.42751437 |
| 78 | Hypotension (HP:0002615) | 2.42716995 |
| 79 | Lethargy (HP:0001254) | 2.39827729 |
| 80 | Multiple lipomas (HP:0001012) | 2.38573207 |
| 81 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.37640981 |
| 82 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.37640981 |
| 83 | Abnormal foot bone ossification (HP:0010675) | 2.35868314 |
| 84 | Protuberant abdomen (HP:0001538) | 2.35761914 |
| 85 | Renal salt wasting (HP:0000127) | 2.35371633 |
| 86 | Acute encephalopathy (HP:0006846) | 2.35019046 |
| 87 | Thin bony cortex (HP:0002753) | 2.31452930 |
| 88 | Hepatic necrosis (HP:0002605) | 2.30156361 |
| 89 | Hemorrhage of the eye (HP:0011885) | 2.29308293 |
| 90 | Dicarboxylic aciduria (HP:0003215) | 2.29245134 |
| 91 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.29245134 |
| 92 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.26499530 |
| 93 | Pheochromocytoma (HP:0002666) | 2.23887752 |
| 94 | Hypolipoproteinemia (HP:0010981) | 2.23850839 |
| 95 | Pili torti (HP:0003777) | 2.21798421 |
| 96 | Hyponatremia (HP:0002902) | 2.20824517 |
| 97 | Hyperkalemia (HP:0002153) | 2.20561950 |
| 98 | Neoplasm of the rectum (HP:0100743) | 2.18573403 |
| 99 | Nausea (HP:0002018) | 2.18233513 |
| 100 | Neuroendocrine neoplasm (HP:0100634) | 2.17244037 |
| 101 | Abnormality of purine metabolism (HP:0004352) | 2.16893132 |
| 102 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.16671576 |
| 103 | Pigmentary retinal degeneration (HP:0001146) | 2.15485571 |
| 104 | Lipid accumulation in hepatocytes (HP:0006561) | 2.14229444 |
| 105 | Exocrine pancreatic insufficiency (HP:0001738) | 2.13925056 |
| 106 | Proximal tubulopathy (HP:0000114) | 2.13679677 |
| 107 | Abnormality of the gastric mucosa (HP:0004295) | 2.11802603 |
| 108 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.10859644 |
| 109 | Complement deficiency (HP:0004431) | 2.10582917 |
| 110 | Abnormal EKG (HP:0003115) | 2.07609981 |
| 111 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.06783957 |
| 112 | Nephritis (HP:0000123) | 2.06730131 |
| 113 | Mitochondrial inheritance (HP:0001427) | 2.06373176 |
| 114 | Rhabdomyolysis (HP:0003201) | 2.05710057 |
| 115 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.04622617 |
| 116 | Villous atrophy (HP:0011473) | 2.04622617 |
| 117 | Abnormality of complement system (HP:0005339) | 2.04260770 |
| 118 | Recurrent bronchitis (HP:0002837) | 2.04097267 |
| 119 | Hyperphosphatemia (HP:0002905) | 2.02825507 |
| 120 | Acute necrotizing encephalopathy (HP:0006965) | 2.01122437 |
| 121 | Widely patent fontanelles and sutures (HP:0004492) | 1.99051037 |
| 122 | Hyperglycinuria (HP:0003108) | 1.98164036 |
| 123 | Pustule (HP:0200039) | 1.97530202 |
| 124 | Ventricular arrhythmia (HP:0004308) | 1.96601283 |
| 125 | Acanthocytosis (HP:0001927) | 1.95608122 |
| 126 | Atelectasis (HP:0100750) | 1.94525865 |
| 127 | Gastrointestinal dysmotility (HP:0002579) | 1.94522276 |
| 128 | Neoplasm of the small intestine (HP:0100833) | 1.93601058 |
| 129 | Hyperphosphaturia (HP:0003109) | 1.93502573 |
| 130 | Increased purine levels (HP:0004368) | 1.92785013 |
| 131 | Hyperuricemia (HP:0002149) | 1.92785013 |
| 132 | Eczematoid dermatitis (HP:0000976) | 1.92456897 |
| 133 | Biliary tract neoplasm (HP:0100574) | 1.92425602 |
| 134 | Steatorrhea (HP:0002570) | 1.92313770 |
| 135 | Deep venous thrombosis (HP:0002625) | 1.91554224 |
| 136 | Hypercholesterolemia (HP:0003124) | 1.88928215 |
| 137 | Cerebral edema (HP:0002181) | 1.87775317 |
| 138 | Growth hormone excess (HP:0000845) | 1.87382111 |
| 139 | Hypokalemia (HP:0002900) | 1.86783239 |
| 140 | Abnormal biliary tract morphology (HP:0012440) | 1.85075579 |
| 141 | Abnormal hair laboratory examination (HP:0003328) | 1.84100305 |
| 142 | Symptomatic seizures (HP:0011145) | 1.82989146 |
| 143 | Megaloblastic anemia (HP:0001889) | 1.81975630 |
| 144 | Hyperlipoproteinemia (HP:0010980) | 1.80736167 |
| 145 | Occipital encephalocele (HP:0002085) | 1.80029764 |
| 146 | Hepatocellular necrosis (HP:0001404) | 1.79836106 |
| 147 | Rectal prolapse (HP:0002035) | 1.78661677 |
| 148 | Increased hepatocellular lipid droplets (HP:0006565) | 1.78160254 |
| 149 | Wide cranial sutures (HP:0010537) | 1.78126229 |
| 150 | Esophageal neoplasm (HP:0100751) | 1.77735870 |
| 151 | Neoplasm of head and neck (HP:0012288) | 1.77735870 |
| 152 | Adrenal overactivity (HP:0002717) | 1.74580452 |
| 153 | Abnormal glucose tolerance (HP:0001952) | 1.73743781 |
| 154 | Abnormality of potassium homeostasis (HP:0011042) | 1.72480714 |
| 155 | Abnormal tarsal ossification (HP:0008369) | 1.71685105 |
| 156 | Hypophosphatemia (HP:0002148) | 1.71521477 |
| 157 | Abnormality of sodium homeostasis (HP:0010931) | 1.71233242 |
| 158 | Gout (HP:0001997) | 1.70273054 |
| 159 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.69733412 |
| 160 | Dehydration (HP:0001944) | 1.68817517 |
| 161 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.62848818 |
| 162 | Vascular calcification (HP:0004934) | 1.57750006 |
| 163 | Renal tubular acidosis (HP:0001947) | 1.56559927 |
| 164 | Nephrolithiasis (HP:0000787) | 1.55576434 |
| 165 | Flattened epiphyses (HP:0003071) | 1.54481416 |
| 166 | Stridor (HP:0010307) | 1.49051664 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 5.94065492 |
| 2 | NME1 | 5.93630731 |
| 3 | ACVR1B | 4.48387024 |
| 4 | MAPK15 | 4.21360631 |
| 5 | MAP2K2 | 3.93583575 |
| 6 | RPS6KB2 | 3.83665879 |
| 7 | MST4 | 2.97327501 |
| 8 | LMTK2 | 2.70735811 |
| 9 | MST1R | 2.68306601 |
| 10 | PTK6 | 2.47183829 |
| 11 | ERN1 | 2.44408823 |
| 12 | BLK | 2.27682428 |
| 13 | MAP2K6 | 2.00371973 |
| 14 | TAOK1 | 1.99080301 |
| 15 | TEC | 1.97646298 |
| 16 | PIK3CA | 1.95867473 |
| 17 | TESK1 | 1.89919303 |
| 18 | MAP3K11 | 1.86867778 |
| 19 | STK24 | 1.83152259 |
| 20 | MAP3K2 | 1.77687191 |
| 21 | EPHA3 | 1.76942598 |
| 22 | FGFR4 | 1.76685796 |
| 23 | PRKG2 | 1.75602240 |
| 24 | MAP2K1 | 1.72594137 |
| 25 | CAMK2D | 1.70342027 |
| 26 | CAMK2B | 1.65774369 |
| 27 | MAP3K12 | 1.65525367 |
| 28 | EPHB2 | 1.61353301 |
| 29 | GRK6 | 1.58407348 |
| 30 | EPHB1 | 1.54027072 |
| 31 | SMG1 | 1.53648966 |
| 32 | EEF2K | 1.53484072 |
| 33 | TRIB3 | 1.52917843 |
| 34 | MYLK | 1.47548711 |
| 35 | KSR2 | 1.40005163 |
| 36 | CAMK2G | 1.36557818 |
| 37 | TYK2 | 1.34950164 |
| 38 | PKN2 | 1.31244099 |
| 39 | MAP3K10 | 1.19387860 |
| 40 | PIM2 | 1.13864177 |
| 41 | PAK4 | 1.11427882 |
| 42 | MAP3K3 | 1.05028929 |
| 43 | TAOK3 | 1.02794236 |
| 44 | PTK2 | 1.00509436 |
| 45 | FGFR3 | 0.88232826 |
| 46 | CDC42BPA | 0.86530893 |
| 47 | ILK | 0.86109565 |
| 48 | MAP3K8 | 0.85921300 |
| 49 | NME2 | 0.84650000 |
| 50 | MAP3K1 | 0.77877546 |
| 51 | MAP3K7 | 0.77028618 |
| 52 | LIMK1 | 0.74037113 |
| 53 | LRRK2 | 0.73222587 |
| 54 | MET | 0.72771529 |
| 55 | FER | 0.71667174 |
| 56 | NUAK1 | 0.71236519 |
| 57 | LATS1 | 0.70072608 |
| 58 | CSK | 0.69460123 |
| 59 | TESK2 | 0.68414084 |
| 60 | MAPK11 | 0.68389130 |
| 61 | RIPK1 | 0.65692462 |
| 62 | ERBB2 | 0.62487688 |
| 63 | ZAP70 | 0.60003243 |
| 64 | NEK6 | 0.59257914 |
| 65 | IKBKE | 0.57995997 |
| 66 | RIPK4 | 0.57277717 |
| 67 | MAPKAPK3 | 0.57110475 |
| 68 | PRKCQ | 0.56730077 |
| 69 | NLK | 0.56486658 |
| 70 | STK10 | 0.54422756 |
| 71 | PRKCI | 0.54108444 |
| 72 | RET | 0.53020090 |
| 73 | IRAK1 | 0.52727635 |
| 74 | DYRK1B | 0.52549459 |
| 75 | MUSK | 0.52056495 |
| 76 | ABL2 | 0.51069206 |
| 77 | MAP3K6 | 0.49656751 |
| 78 | PAK1 | 0.49431845 |
| 79 | TBK1 | 0.48178062 |
| 80 | MAP4K1 | 0.47183701 |
| 81 | PAK3 | 0.45751451 |
| 82 | STK39 | 0.45579841 |
| 83 | PBK | 0.44072734 |
| 84 | PDK4 | 0.43543106 |
| 85 | PDK3 | 0.43543106 |
| 86 | SIK1 | 0.43462563 |
| 87 | CAMK1 | 0.43349186 |
| 88 | DAPK3 | 0.42479886 |
| 89 | TAOK2 | 0.42270686 |
| 90 | YES1 | 0.41021732 |
| 91 | SCYL2 | 0.41016588 |
| 92 | PRKCA | 0.40967038 |
| 93 | SRC | 0.40286102 |
| 94 | MAPKAPK2 | 0.40112534 |
| 95 | GRK1 | 0.39849712 |
| 96 | BMPR2 | 0.39312730 |
| 97 | CSNK1A1 | 0.39282698 |
| 98 | RPS6KA2 | 0.37365018 |
| 99 | ITK | 0.36777945 |
| 100 | AKT3 | 0.36573138 |
| 101 | CAMK2A | 0.35300261 |
| 102 | DMPK | 0.35034103 |
| 103 | BMX | 0.34621000 |
| 104 | PRKACG | 0.31878136 |
| 105 | JAK1 | 0.31736341 |
| 106 | TLK1 | 0.31436078 |
| 107 | CASK | 0.31434345 |
| 108 | PDPK1 | 0.28752654 |
| 109 | HIPK2 | 0.28515081 |
| 110 | DAPK2 | 0.27611516 |
| 111 | CAMKK1 | 0.27017619 |
| 112 | ERBB4 | 0.25077532 |
| 113 | PRKCE | 0.24824334 |
| 114 | PRKAA2 | 0.24424820 |
| 115 | MAP2K3 | 0.24031634 |
| 116 | PRKCD | 0.23174679 |
| 117 | KDR | 0.23064751 |
| 118 | EPHA2 | 0.22838301 |
| 119 | BCKDK | 0.22788969 |
| 120 | CDK19 | 0.22512902 |
| 121 | OXSR1 | 0.21425160 |
| 122 | CHUK | 0.21311685 |
| 123 | FYN | 0.20215090 |
| 124 | MATK | 0.19587619 |
| 125 | CDK6 | 0.17391438 |
| 126 | EIF2AK1 | 0.17284456 |
| 127 | SGK1 | 0.16949039 |
| 128 | JAK2 | 0.16947953 |
| 129 | DDR2 | 0.16751348 |
| 130 | PDK1 | 0.16728605 |
| 131 | ICK | 0.16723373 |
| 132 | WNK4 | 0.16699257 |
| 133 | LYN | 0.16588086 |
| 134 | CSNK1G3 | 0.15725787 |
| 135 | PRKCZ | 0.15405080 |
| 136 | IGF1R | 0.14624864 |
| 137 | TTK | 0.14534835 |
| 138 | EPHA4 | 0.13242076 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Fat digestion and absorption_Homo sapiens_hsa04975 | 4.70502306 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.45623710 |
| 3 | Sulfur metabolism_Homo sapiens_hsa00920 | 3.36932963 |
| 4 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 3.36022547 |
| 5 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 3.28893410 |
| 6 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 3.15408575 |
| 7 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.64616181 |
| 8 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.56411525 |
| 9 | Histidine metabolism_Homo sapiens_hsa00340 | 2.36555219 |
| 10 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.24932980 |
| 11 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 2.07927602 |
| 12 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.05727681 |
| 13 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.98972986 |
| 14 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.88149403 |
| 15 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.85446488 |
| 16 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.83293662 |
| 17 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.80209568 |
| 18 | Bile secretion_Homo sapiens_hsa04976 | 1.77475363 |
| 19 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.77158925 |
| 20 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.73765279 |
| 21 | Mineral absorption_Homo sapiens_hsa04978 | 1.70529794 |
| 22 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.69171286 |
| 23 | Galactose metabolism_Homo sapiens_hsa00052 | 1.65424132 |
| 24 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.60954049 |
| 25 | Asthma_Homo sapiens_hsa05310 | 1.60581527 |
| 26 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.54702853 |
| 27 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.52550652 |
| 28 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.51924758 |
| 29 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.50043488 |
| 30 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.47453296 |
| 31 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.45538377 |
| 32 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.44520487 |
| 33 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.44195193 |
| 34 | Parkinsons disease_Homo sapiens_hsa05012 | 1.37346181 |
| 35 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.32376148 |
| 36 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.27138513 |
| 37 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.26954431 |
| 38 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.26334210 |
| 39 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.23060272 |
| 40 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.22447667 |
| 41 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.12227745 |
| 42 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.10550098 |
| 43 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.09732051 |
| 44 | Alzheimers disease_Homo sapiens_hsa05010 | 1.09359770 |
| 45 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.05612466 |
| 46 | Allograft rejection_Homo sapiens_hsa05330 | 1.03014229 |
| 47 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.02532076 |
| 48 | Carbon metabolism_Homo sapiens_hsa01200 | 1.02453070 |
| 49 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.00918158 |
| 50 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.98404077 |
| 51 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.96278158 |
| 52 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.95835347 |
| 53 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.94128251 |
| 54 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.92937691 |
| 55 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.90994325 |
| 56 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.90122262 |
| 57 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.89701774 |
| 58 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.87767279 |
| 59 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.86390589 |
| 60 | Tight junction_Homo sapiens_hsa04530 | 0.84635426 |
| 61 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.83887622 |
| 62 | Hepatitis C_Homo sapiens_hsa05160 | 0.83701516 |
| 63 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.81734862 |
| 64 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.78230129 |
| 65 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.77835694 |
| 66 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.76537636 |
| 67 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.74017220 |
| 68 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.73630383 |
| 69 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.73393340 |
| 70 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.72485444 |
| 71 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.69985734 |
| 72 | Other glycan degradation_Homo sapiens_hsa00511 | 0.67933134 |
| 73 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.67830917 |
| 74 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.67612610 |
| 75 | Huntingtons disease_Homo sapiens_hsa05016 | 0.67592256 |
| 76 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.65349604 |
| 77 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.65236339 |
| 78 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.64685092 |
| 79 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.62969984 |
| 80 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.62219817 |
| 81 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.59669009 |
| 82 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.56201251 |
| 83 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.55801628 |
| 84 | Sulfur relay system_Homo sapiens_hsa04122 | 0.51943169 |
| 85 | Thyroid cancer_Homo sapiens_hsa05216 | 0.46521532 |
| 86 | Peroxisome_Homo sapiens_hsa04146 | 0.46507398 |
| 87 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.42633597 |
| 88 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.40633183 |
| 89 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.40224921 |
| 90 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.40198131 |
| 91 | ABC transporters_Homo sapiens_hsa02010 | 0.38584564 |
| 92 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.38519524 |
| 93 | Metabolic pathways_Homo sapiens_hsa01100 | 0.38381036 |
| 94 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.36364101 |
| 95 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.35423079 |
| 96 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.34857766 |
| 97 | Bladder cancer_Homo sapiens_hsa05219 | 0.34393065 |
| 98 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.34325413 |
| 99 | Retinol metabolism_Homo sapiens_hsa00830 | 0.34231791 |
| 100 | Leishmaniasis_Homo sapiens_hsa05140 | 0.34223748 |
| 101 | Salmonella infection_Homo sapiens_hsa05132 | 0.34170523 |
| 102 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.32335227 |
| 103 | Insulin resistance_Homo sapiens_hsa04931 | 0.30930862 |
| 104 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.29662478 |
| 105 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.27451325 |
| 106 | Cocaine addiction_Homo sapiens_hsa05030 | 0.26733769 |
| 107 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.23351516 |
| 108 | Pertussis_Homo sapiens_hsa05133 | 0.22586170 |
| 109 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.21701724 |
| 110 | Insulin secretion_Homo sapiens_hsa04911 | 0.21585964 |
| 111 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.20618540 |
| 112 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.20406801 |
| 113 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.20363663 |
| 114 | Salivary secretion_Homo sapiens_hsa04970 | 0.20326805 |
| 115 | Viral myocarditis_Homo sapiens_hsa05416 | 0.16530559 |
| 116 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.15914290 |
| 117 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.14948586 |
| 118 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.14409599 |
| 119 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.14014646 |
| 120 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.13338148 |
| 121 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.12797788 |
| 122 | Amoebiasis_Homo sapiens_hsa05146 | 0.11910370 |
| 123 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.11835804 |
| 124 | Renin secretion_Homo sapiens_hsa04924 | 0.11606102 |
| 125 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.10874441 |
| 126 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.10692070 |
| 127 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.10604659 |
| 128 | Lysosome_Homo sapiens_hsa04142 | 0.09906802 |
| 129 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.09501255 |
| 130 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.08949580 |
| 131 | Influenza A_Homo sapiens_hsa05164 | 0.07689944 |
| 132 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.06625161 |

